2020 annual financial data
Heron Therapeutics 2020 Operating margin
Direct answer
Operating margin was -257.41%.
Operating income was -228,163,000 USD and net income was -224,431,000 USD.
Operating cash flow was -184,820,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 88,638,000 USD
- Operating income
- -228,163,000 USD
- Net income
- -224,431,000 USD
- Operating cash flow
- -184,820,000 USD